<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01231815</url>
  </required_header>
  <id_info>
    <org_study_id>2008-007746-58</org_study_id>
    <nct_id>NCT01231815</nct_id>
  </id_info>
  <brief_title>Coronary Flow Reserve Evaluation in PET and in MRI Scanner in Heart Transplanted Patients : Comparison With Multi-detectors Scanner</brief_title>
  <acronym>RECOPE</acronym>
  <official_title>Coronary Flow Reserve Evaluation in PET and in MRI Scanner in Heart Transplanted Patients : Comparison With Multi-detectors Scanner</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Heart transplantation is the ultimate therapeutic option in patients with end-stage heart
      failure. Since advances in the treatment of acute rejection has increased early transplant
      survival, cardiac allograft vasculopathy (CAV) is the main factor limiting long-term
      survival. The prevalence of angiographically proven CAV is high, documented in 40-50% of
      transplant recipients 5 years after transplantation. Therefore, annual coronary angiography
      remains widely used to monitor transplanted patients, although pathologic studies and
      intravascular ultrasonography have demonstrated that coronary angiography underestimates the
      severity of CAV. Perfusion SPECT may underestimate allograft vasculopathy in case of diffuse
      coronary lesions. In this setting, the assessment of coronary reserve by means of Positron
      Emission Tomography (PET) and perfusion cardiac magnetic resonance imaging (CMR) have not
      been investigated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim of the study. The aim of the study is to compare the quantitative (using 15O-H2O PET) and
      semi-quantitative (using perfusion CMR) assessment of coronary reserve to the presence of
      coronary artery lesions documented by multidetector CT coronary angiography.

      Methods. 30 patients with heart transplantation &gt; 3 yrs will be included in two heart
      transplantation centers (Caen and Rouen university hospitals)

      Expected results.

        -  To demonstrate that quantitative analysis of coronary reserve using 15O-H2O PET allows
           the assessment of cardiac allograft vasculopathy

        -  To establish the feasibility of adenosine stress CMR in this population

        -  To show a relationship between coronary lesions demonstrated using MDCT and the extent
           of coronary reserve impairment assessed using cardiac functional imaging (PET and CMR).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2010</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To compare the coronary flow reserve by a quantitative method (PET ...</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Heart Disease</condition>
  <arm_group>
    <arm_group_label>PET</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15O-H2O PET</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MRI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MRI</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>15O-H2O PET -</intervention_name>
    <description>Assessment of coronary reserve using PET</description>
    <arm_group_label>PET</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>Assessment of coronary reserve using MRI</description>
    <arm_group_label>MRI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with heart transplantation &gt; 3 years

          -  Candidate to a routine coronary angiography

          -  Age &gt; 18 years old

          -  signed informed consent

        Exclusion Criteria:

          -  Pregnancy or breast feeding women

          -  Recent acute coronary syndrome (&lt;4weeks)

          -  High Blood Pressure ((SBP &gt;=180 mmHg or DBP &gt;=110 mmHg)

          -  Significant ventricular or supraventricular arrythmia

          -  Atrioventricular 2nd or 3rd degree blocks, long QT syndrome

          -  Standard contraindications to MRI including pacemaker/defibrillator, metallic clips on
             brain aneurysms, metal fragment in the eye etc...

          -  Congestive heart failure

          -  Hemodynamic instability

          -  Intolerance or contraindication to adenosine (history of asthma or bronchoplastic
             disease).

          -  Severe and known pulmonary artery hypertension

          -  Severe hypotension &lt; 90 mmHg

          -  Contraindication to contrast iodinated media (allergy, patients with chronic renal
             failure with creatinine clearance &lt; 50 ml/min, multiple myeloma, hyperthyroidism,...)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alain Manrique, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>GIP Cyceron - CHU de Caen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alain MANRIQUE, MD</last_name>
    <phone>+33 2 31 47 02 87</phone>
    <email>manrique@cyceron.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Denis AGOSTINI, PhD</last_name>
    <phone>+33 2 31 06 32 46</phone>
    <email>agostini-d@chu-caen.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Caen - GIP Cyceron</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain MANRIQUE, MD</last_name>
      <phone>+33 2 31 47 02 82</phone>
      <email>manrique@cyceron.fr</email>
    </contact>
    <contact_backup>
      <last_name>Cynthia BONDIS</last_name>
      <phone>+33 2 31 06 57 80</phone>
      <email>bondis-c@chu-caen.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Rémi SABATIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Annette BELIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michèle HAMON, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Rouen</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel REDONNET, MD</last_name>
      <phone>+33 2 32 88 81 97</phone>
      <email>Michel.Redonnet@chu-rouen.fr</email>
    </contact>
    <contact_backup>
      <last_name>Catherine NAFEH, MD</last_name>
      <phone>+33 2 32 88 81 97</phone>
      <email>catherine.nafeh-bizet@chu-rouen.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Jean-Nicolas DACHER, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 29, 2010</study_first_submitted>
  <study_first_submitted_qc>October 29, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2010</study_first_posted>
  <last_update_submitted>April 8, 2014</last_update_submitted>
  <last_update_submitted_qc>April 8, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 9, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart transplantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

